The NHMRC-EU Collaborative Research Grants scheme provides a contribution to Australian institutions and researchers who are participating in leading international collaborative research that has been selected for funding through Horizon 2020. Horizon 2020 is currently the EU’s main instrument for funding research and development and will run until 2020.
Further information on Horizon 2020, including the timing and application process for EU topics, is available from the EU website.
Grant value is estimated at up to AUD $500,000, for up to five years.
Applications must be made to, and approved through the European Commission (EC) peer review process to be eligible for funding through NHMRC.
Eligible topics for 2019 Funding (Round 1)
- SC1-BHC-03-2018: Exploiting research outcomes and application potential of the human microbiome for personalised prediction, prevention and treatment of disease.
- SC1-BHC-05-2018: International flagship collaboration with Canada for human data storage, integration and sharing to enable personalised medicine approaches.
- SC1-BHC-09-2018: Innovation platforms for advanced therapies of the future.
- SC1-BHC-23-2018: Novel patient-centred approaches for survivorship, palliation and/or end-of-life care.
- SC1-BHC-26-2018: HTA research to support evidence-based healthcare.
- SC1-BHC-27-2018: New testing and screening methods to identify endocrine disrupting chemicals.
- SC1-DTH-03-2018: Adaptive smart working and living environments supporting active and healthy ageing.
- SC1-DTH-07-2018: Exploiting the full potential of in-silico medicine research for personalised diagnostics and therapies in cloud-based environments.
- SU-TDS-02-2018: Toolkit for assessing and reducing cyber risks in hospitals and care centres to protect data/infrastructures.
Eligible topics for 2019 Funding (Round 2)
- SC1-BHC-15-2018: New anti-infective agents for prevention and/or treatment of neglected infectious diseases (NID).
Eligible Topics for 2020 Funding
- SC1-BHC-01-2019: Understanding causative mechanisms in co- and multimorbidities.
- SC1-BHC-02-2019: Systems approaches for the discovery of combinatorial therapies for complex disorders.
- SC1-BHC-07-2019: Regenerative medicine: from new insights to new applications.
- SC1-BHC-13-2019: Mining big data for early detection of infectious disease threats driven by climate change and other factors.
- SC1-BHC-14-2019: Stratified host-directed approaches to improve prevention and/or treatment of infectious diseases.
- SC1-BHC-19-2019: Implementation research for maternal and child health.
- SC1-BHC-22-2019: Mental health in the workplace.
- SC1-BHC-25-2019: Demonstration pilots for implementation of personalised medicine in healthcare.
- SC1-BHC-28-2019: The Human Exposome Project: a toolbox for assessing and addressing the impact of environment on health.
- SC1-DTH-01-2019: Big data and Artificial Intelligence for monitoring health status and quality of life after the cancer treatment.
Submission Requirements & Due Date
- Applications must be submitted for internal review by 17 May 2019
- Please complete your RFR through ResearchMaster using Fund Scheme code 51301009
- See also: Submitting an Application to Research Services for Review